Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...

- Nine abstracts across Takeda’s hematology portfolio and pipeline demonstrate Takeda’s commitment to patient-centric, innovative care that aims to drive greater treatment outcomes - Includes data ...

What if we could repair fundamental parts of our bodies? Gene therapy promises just that. It's like having a molecular mechanic that can fix or replace faulty genes, potentially curing diseases ...

Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade in efforts to develop next-gen gene therapies for sickle ...

Researchers are leading a study into nipocalimab, a new investigational drug that's showing promise in treating a rare blood disease in babies. It could help prevent anemia and cut down on the need ...

A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders.

A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders.

Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.

The American Society of Hematology (ASH) and nearly 100 other organizations blasted the dismantling of CDC's Division of Blood Disorders and Public Health Genomics (DBDPHG) and called for its full ...

Share on Pinterest Blood tests may help detect some neurodegenerative diseases in the future. Patricio Nahuelhual/Getty Images Researchers have discovered a blood marker they say can help in ...